New Delhi: As a nation, we face several challenges including affordable healthcare, clean fuels, clean water, agricultural productivity, drought, malnutrition, infectious diseases like dengue and chikungunya, non-communicable diseases like diabetes, cancer, cardiovascular, and respiratory diseases, animal health, environmental pollution, waste management etc.
Biotechnology has disruptive solutions to each one of these challenges and is at the core of a transformative BioEconomy. India’s entrepreneurs have scaled up innovative, research-led businesses to deliver a wide variety of products and services in the field of vaccines, drugs, diagnostics, agricultural crops, enzymes, biofuels, genomics, bioengineering, drug research and associated services.
In the above context, the BioEconomy India Conclave 2016 is India’s first premier conference focused on biotechnology and its impact on the economy. Being hosted by the Association of Biotechnology Led Enterprises (ABLE), the event is an opportunity to discuss, debate, partner and contribute to bringing about the transformative change in economic development through the power of biotechnology.
The conclave will provide a platform to all the stakeholders of the BioEconomy such as researchers, technologists, entrepreneurs, and businesses that are driving innovation in healthcare, agriculture, industrial processes, renewable energy and beyond through products and services.
The Association of Biotechnology Led Enterprises (ABLE) is organizing the BioEconomy India Conclave 2016 on November 29-30 at India Habitat Centre, Delhi. India’s first conclave focused on an all-encompassing BioEconomy—an economy that is driven by meeting the societal needs of food, fuel, health and environmental sustainability.
The event is expected to be attended by close to 300 delegates cutting across various industry verticals. The platform will discuss, debate, network, and partner to bring about the potential of transformative change in economic development through the power of biotechnology. The full conference agenda and speakers list can be viewed by visiting the site here.
In her comments on the major objective behind the event, Dr Kiran Mazumdar-Shaw, Honorary Non Executive Chairman of ABLE, and CMD at Biocon mentioned, “The conclave aims to create a nationwide awareness of the economic potential of Biotechnology across various sectors viz Healthcare, Agriculture, Energy and Sustainable solutions for Industry. It also aims to bring policy makers, the Departments of Biotechnology, the ministries of Health, Food & Agriculture, Environment, the Department of Industrial Policy & Promotion (DIPP), and NITI Aayog onto a common platform.”
ABLE has been conducting various programs in partnership with BIRAC to spur the start-up ecosystem. Of these, BEST (Biotech Entrepreneurship for Student Teams) has been enormously successful and has led to several start-ups. We have also been conducting an annual BioInvest event to bring the financing community together with aspiring start-ups in order to provide much needed capital to these small enterprises who are at various stages of their businesses.
The size of the Indian BioEconomy has been estimated to be a little over $35 billion in 2015 providing employment to a million highly qualified people. The Indian BioEconomy has the potential to reach $100 billion by 2025 and create more than 10 million (1 crore) high-value jobs in the national economy.
Mr P M Murali, President, Association of Biotechnology Led Enterprises and Managing Director and CEO, Evolva India, mentioned, “A country’s backbone is its Bioeconmy. We are at currently around $35 billion, we need to get to $100 billion soon and this would propel manufacturing and employment. People forget that by doing this, a huge social infrastructure will also develop around it which is good for the country and its general economy.”
“Agriculture, climate change, animal heath, disease mitigation, vaccines for the future and health and wellness related products for human and animal longevity. To cater to these verticals you need to put end-to-end infrastructure in place for both Indian and MNC companies to participate in a meaningful way. Meaning from concept to commercialization including manufacturing there has to be conducive infrastructure and regulatory practices. Besides this, there is going to be a huge need for skilling of manpower,” added Mr Murali.”
The BioEconomy Conclave 2016 is an opportunity to discuss, debate, partner and contribute to bringing about the transformative change in economic development through the power of Biotechnology. The conclave will provide a platform to all stakeholders in the BioEconomy — researchers, technologists, administrators, entrepreneurs and businesses that are driving innovation in healthcare, agriculture, industrial processes, renewable energy and beyond through products and services.
Biovoice news is the official media partner of the BioEconomy Conclave 2016. We will bring you latest updates and the exclusive insights from the event.
The first day of the event is packed with the sessions on important topics and will be attended by the ministers and top government officials alongwith the prominent voices from the industry. Second day of the event will present an opportunity due to the unique session–VOICE FOR BT–on the evening of November 29th. VOICE FOR BT is a public speaking contest to encourage undergraduate students from colleges to speak passionately on topics such as biofules, nutrition and water conservation.
This is a national contest and is being supported by Novozymes, a world leader in biological solutions. Eight finalists will vie for the final round on November 29th. These eight speakers have made it to the grand finale after a gruelling contest in their respective regional selections – West, South, North and East.